e-learning
resources
London 2016
Tuesday, 06.09.2016
Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
5-year weekly monitoring of community-acquired pneumonia incidence and mortality
Rustem Shaymuratov (Kazan, Republic of Tatarstan, Russian Federation), Rustem Shaymuratov, Alexander Vizel
Source:
International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Session:
Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Session type:
Thematic Poster
Number:
4247
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rustem Shaymuratov (Kazan, Republic of Tatarstan, Russian Federation), Rustem Shaymuratov, Alexander Vizel. 5-year weekly monitoring of community-acquired pneumonia incidence and mortality. Eur Respir J 2016; 48: Suppl. 60, 4247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Antimicrobial therapy of community-acquired pneumonia (CAP) at an out-patient stage in the Samara region during the 5-year period
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Determinants of hospital costs in community-acquired pneumonia
Source: Eur Respir J 2008; 31: 1061-1067
Year: 2008
Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Factors affecting short and long-term mortality after community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume
Source: Eur Respir J 2003; 22: 148-155
Year: 2003
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia
Source: International Congress 2014 – How quality of care impacts cost effectiveness
Year: 2014
Medications associated with the incidence of recurrent pneumonia in Japanese elderly population
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized
streptococcus pneumoniae
pneumonia in Norway 2008-2009
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Quality indicators for management of community-acquired pneumonia
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept